Self-limited hemolysis due to anti-D passenger lymphocyte syndrome in allogeneic hematopoietic stem cell transplantation

Bone Marrow Transplantation

Volumn 45, Issue 4, 2010, Pages 772-773

  Adams, B R ^a   Miller, A N ^a   Costa, L J ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP A ANTIBODY; BLOOD GROUP A ANTIGEN; BLOOD GROUP B ANTIBODY; BLOOD GROUP B ANTIGEN; CYCLOSPORIN; DASATINIB; FLUDARABINE; HEMOGLOBIN; IMATINIB; IMMUNOGLOBULIN G ANTIBODY; MELPHALAN; METHOTREXATE; MYCOPHENOLIC ACID; RHESUS ANTIGEN; RHESUS D ANTIBODY;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOIMMUNIZATION; ANTIBODY SCREENING; BLOOD GROUP TYPING; CASE REPORT; CHIMERA; CHRONIC MYELOID LEUKEMIA; COOMBS TEST; CORONARY ARTERY DISEASE; DONOR SELECTION; ENGRAFTMENT; ERYTHROCYTE TRANSFUSION; ERYTHROPOIESIS; FEVER; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBINURIA; HUMAN; HYDRATION; IMMUNE DEFICIENCY; INTRAVASCULAR HEMOLYSIS; LABORATORY TEST; LETTER; LEUKEMIA REMISSION; MALE; PALLIATIVE THERAPY; PASSENGER LYMPHOCYTE SYNDROME; PRIORITY JOURNAL; RHESUS ISOIMMUNIZATION; RISK FACTOR;

ANEMIA, HEMOLYTIC; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; ISOANTIBODIES; MALE; MIDDLE AGED; TRANSPLANTATION, HOMOLOGOUS;

EID: 77950628003     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2009.202     Document Type: Letter

References (9)

1. Gajewski JL, Johnson VV, Sandler SG, Sayegh A, Klumpp TR. A review of transfusion practice before, during, and after hematopoietic progenitor cell transplantation. Blood 2008; 112: 3036-3047.
2. Worel N, Greinix HT, Keil F, Mitterbauer M, Lechner K, Fischer G et al. Severe immune hemolysis after minor ABOmismatched allogeneic peripheral blood progenitor cell transplantation occurs more frequently after nonmyeloablative than myeloablative conditioning. Transfusion 2002; 42: 1293-1301.
3. Hows J, Beddow K, Gordon-Smith E, Branch DR, Spruce W, Sniecinski I et al. Donor-derived red blood cell antibodies and immune hemolysis after allogeneic bone marrow transplantation. Blood 1986; 67: 177-181. (Pubitemid 16167029)
4. Leo A, Mytilineos J, Voso MT, Weber-Nordt R, Liebisch P, Lensing C et al. Passenger lymphocyte syndrome with severe hemolytic anemia due to an anti-Jk(a) after allogeneic PBPC transplantation. Transfusion 2000; 40: 632-636. (Pubitemid 30413313)
5. Young PP, Goodnough LT, Westervelt P, Diersio JF. Immune hemolysis involving non-ABO/RhD alloantibodies following hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 27: 1305-1310. (Pubitemid 32655400)
6. Franchini M, Gandini G, Aprili G. Non-ABO red blood cell alloantibodies following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2004; 33: 1169-1172. (Pubitemid 38961472)
7. Gandini G, Franchini M, De Gironcoli M, Vassanelli A, Benedetti F, Turrini A et al. Detection of an anti-RhD antibody years after sensitization in a patient who had undergone an allogeneic BMT. Bone Marrow Transplant 2000; 25: 457-459. (Pubitemid 30114043)
8. Lee HJ, Gulbis A, De Padua Silva L, Hosing C, Khouri I, de Lima M et al. Rituximab for passenger lymphocyte syndrome associated with allogeneic SCT. Bone Marrow Transplant 2008; 42: 67-69. (Pubitemid 352003429)
9. Gajewski JL, Petz LD, Calhoun L, O'Rourke S, Landaw EM, Lyddane NR et al. Hemolysis of transfused group O red blood cells in minor ABO-incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate. Blood 1992; 79: 3076-3085.